Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00195806
Status:
COMPLETED
Last Update Posted:
2007-09-03
First Post:
2005-09-14
Brief Title:
Study Designed to Evaluate the Safety of Prophylactic Depakote ER in the Treatment of Adolescents With Migraine
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
Divalproex Sodium Extended-Release Tablets for Migraine Prophylaxis in Adolescents An Open-Label Long-Term Safety Study
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine if long-term treatment up to 1 year with Depakote ER is safe in the reduction of occurrence of migraine headaches in adolescents
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None